IP Library Granted Patent US 10,702,549
Granted Patent B2
US 10,702,549 · App. 16/173,691 · Granted Jul 7, 2020

Methods for treating skin irritation

Inventors: Mark Sampson (Fort Worth, TX); Svetlana Panicheva (Fort Worth, TX); Cary Schockemoehl (Fort Worth, TX); Gerard Dibello (Fort Worth, TX); Vadim Panichev (Fort Worth, TX)
Assignee: URGO US, INC.
A61K33/20A01N59/00A01N59/08A23L3/358A61K9/0014A61K9/06A61K33/10A61K47/02B65D65/38B65D2565/387
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,702,549
App. No.
16/173,691
Granted
Jul 7, 2020
Kind
B2
Abstract

The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solutions, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, and treating skin irritations, among other uses.

Claims (12)

1. A method for treating an irritation of the skin of a subject, comprising: administering a hypochlorous acid composition to an affected area, wherein the composition has an available free chlorine (AFC) content of from about 100 to about 1000 ppm and is stabilized by dissolved inorganic carbon (DIC) in the form of bicarbonate or carbonate of alkaline earth metals and having from about 0.01 to about 1.0% salinity, and a pH of from 4 to 7, wherein the hypochlorous acid composition is a solution, cream, foam, or hydrogel.

2. The method of claim 1 , wherein the irritation is characterized by an inflammatory reaction or hyperinflammation of the skin.

3. The method of claim 2 , wherein the subject has atopic dermatitis, skin allergy, rosacea, psoriasis, or acne.

4. The method of claim 1 , wherein the irritation accompanies a bacterial or viral infection.

5. The method of claim 1 , wherein the subject has a skin fungal infection.

6. The method of claim 1 , wherein the hypochlorous acid composition is created by a process that comprises electrolysis of saline.

7. The method of claim 1 , wherein the hypochlorous acid composition has an AFC content of from about 100 ppm to about 500 ppm.

8. The method of claim 1 , wherein the hypochlorous acid composition has a pH of from 4.4 to 7.

9. The method of claim 1 , wherein the hypochlorous acid composition has a pH of from 5 to 7.

10. The method of claim 1 , wherein the dissolved inorganic carbon (DIC) is present at a molar ratio of from 5:1 to 1:5 with respect to the AFC content.

11. The method of claim 1 , wherein the hypochlorous acid composition contains 300 to 1500 mg/L of a carbonate or bicarbonate salt.

12. The method of claim 1 , wherein the hypochlorous acid composition is provided in a packaging that is nonpermeable to CO 2 or O 2 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2019
From: SAMPSON, MARK; PANICHEVA, SVETLANA; SCHOCKEMOEHL, CARY; DIBELLO, GERALD; PANICHEV, VADIM
To: PURICORE, INC.
Reel/Frame 050762/0033 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2019
From: REALM THERAPEUTICS, INC.
To: URGO US, INC.
Reel/Frame 049405/0191 →
CHANGE OF NAME Recorded Jan 31, 2019
From: PURICORE, INC.
To: REALM THERAPEUTICS, INC.
Reel/Frame 048204/0629 →
Continuity (8)
Continuation 15906347 · Feb 27, 2018
Continuation 15170046 · Jun 1, 2016
Continuation 14572378 · Dec 16, 2014
Continuation In Part 14501977 · Sep 30, 2014
Continuation 13423822 · Mar 19, 2012
Provisional Application 61454383 · Mar 18, 2011
Provisional Application 61526149 · Aug 22, 2011
Related Publication 20190167717A1 · Jun 6, 2019